Literature DB >> 8141758

A comparative study of Mycoplasma gallisepticum vaccines in young chickens.

T Y Abd-el-Motelib1, S H Kleven.   

Abstract

Ten-day-old leghorn chickens were vaccinated with the F, ts-11, or 6/85 strain of Mycoplasma gallisepticum (MG) via the intraocular route or subcutaneously with MG bacterin and challenged by aerosol with the R strain of MG at 30, 60, or 90 days post-vaccination. Respiratory reaction post-vaccination, serological response, persistence of the vaccine strain, and protection against aerosol challenge were compared. In general, the ts-11 and 6/85 strains induced a milder post-vaccination reaction than F-strain, produced a weaker serological response, and did not persist as long in the upper respiratory tract. The F-strain-vaccinated chickens had the fewest and mildest air-sac lesions post-challenge, the 6/85 and ts-11 groups had somewhat less protection, and bacterin-vaccinated chickens had no detectable protection against airsacculitis. The F-strain-vaccinated chickens also had the fewest MG organisms in the trachea 10 days postchallenge.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8141758

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  9 in total

1.  Correlates of immune protection in chickens vaccinated with Mycoplasma gallisepticum strain GT5 following challenge with pathogenic M. gallisepticum strain R(low).

Authors:  Mohammed A Javed; Salvatore Frasca; Debra Rood; Katharine Cecchini; Martha Gladd; Steven J Geary; Lawrence K Silbart
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Comparative genomic analyses of attenuated strains of Mycoplasma gallisepticum.

Authors:  S M Szczepanek; E R Tulman; T S Gorton; X Liao; Z Lu; J Zinski; F Aziz; S Frasca; G F Kutish; S J Geary
Journal:  Infect Immun       Date:  2010-02-01       Impact factor: 3.441

3.  Detection and differentiation of avian mycoplasmas by surface-enhanced Raman spectroscopy based on a silver nanorod array.

Authors:  Suzanne L Hennigan; Jeremy D Driskell; Naola Ferguson-Noel; Richard A Dluhy; Yiping Zhao; Ralph A Tripp; Duncan C Krause
Journal:  Appl Environ Microbiol       Date:  2011-12-30       Impact factor: 4.792

4.  Immunologic Pathways in Protective versus Maladaptive Host Responses to Attenuated and Pathogenic Strains of Mycoplasma gallisepticum.

Authors:  Jessica Beaudet; Edan R Tulman; Katherine Pflaum; Jessica A Canter; Lawrence K Silbart; Steven J Geary
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

5.  Identification and expression of a Mycoplasma gallisepticum surface antigen recognized by a monoclonal antibody capable of inhibiting both growth and metabolism.

Authors:  S Yoshida; A Fujisawa; Y Tsuzaki; S Saitoh
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Effects of the In Ovo Vaccination of the ts-11 Strain of Mycoplasma gallisepticum in Layer Embryos and Posthatch Chicks.

Authors:  Abdulmohsen H Alqhtani; Seyed A Fatemi; Katie E C Elliott; Scott L Branton; Jeff D Evans; Spencer A Leigh; Patrick D Gerard; Edgar D Peebles
Journal:  Animals (Basel)       Date:  2022-04-27       Impact factor: 3.231

7.  Identification of Strain-Specific Sequences That Distinguish a Mycoplasma gallisepticum Vaccine Strain from Field Isolates.

Authors:  Camir Ricketts; Larissa Pickler; John Maurer; Saravanaraj Ayyampalayam; Maricarmen García; Naola M Ferguson-Noel
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

8.  Evaluation in broilers of aerosolized nanoparticles vaccine encapsulating imuno-stimulant and antigens of avian influenza virus/Mycoplasma gallisepticum.

Authors:  Taha Kumosani; Soonham Yaghmoor; Wesam H Abdulaal; Elie Barbour
Journal:  BMC Vet Res       Date:  2020-08-31       Impact factor: 2.741

Review 9.  Current status of vaccine research, development, and challenges of vaccines for Mycoplasma gallisepticum.

Authors:  Muhammad Ishfaq; Wanying Hu; Mohammad Zeb Khan; Ijaz Ahmad; Wenxin Guo; Jichang Li
Journal:  Poult Sci       Date:  2020-06-27       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.